Advertisement
DiSanto Propane (Banner)
Thursday, November 19, 2026NewslettersAdvertiseWatch FL1
GET LOCALGo ad-freeHigh school sportsLocal eventsObituaries
News

Regeneron may lose traction after COVID-19 antibody cocktail taken off market

Regeneron may lose traction after COVID-19 antibody cocktail taken off market

Pharmaceutical developer Regeneron had a great 2021, but the company’s chief financial officer has warned investors not to expect the company to make any sales on their REGEN-COV antibody cocktail in the first half of 2022.

Regeneron’s revenues for 2021 were up 89%, with the company generating $16.07 billion compared to $4.95 billion for the previous year. The company attributed most of its spike in revenue to REGEN-COV, its coronavirus antibody cocktail, according to Albany Times-Union.


Now, Robert Landry, CFO at Regeneron, is warning investors to temper their expectations. The Federal Food and Drug Administration (FDA) retracted REGEN-COV’s use in the U.S this January due to data showing it is “highly unlikely to be active against the omicron variant,” the strain behind the recent spike in COVID-19 cases.

With REGEN-COV’s use on pause, scientists at Regeneron are working to formulate “next generation antibodies” to fight against new COVID-19 variants.

The company had to absorb a $232 million charge to “write down” its REGEN-COV inventory. Regeneron is forecasting spending on research and development to be between $3.1 and $3.4 billion this year, with a 89% gross margin on net product sales as well.

Want to go ad-free?

Become an FL1 member and say goodbye to ads! Plus, you’ll be supporting a company rooted in the Finger Lakes for nearly 30 years.

$4.99 / month

Get ad-free access

Renews monthly. Cancel anytime through your account. Already contributing via Google? Sign in with your Google account and unlock ad-free access. Embedded YouTube videos and other third-party media players may still contain ads.

Start your day with FingerLakes1

Get the stories that matter from across the Finger Lakes, delivered to your inbox.

Your email will be added to our newsletter mailing list, hosted on Substack. Privacy policy